Carolyn Compton, MD PhD

ASU Faculty page
https://search.asu.edu/profile/2008177

Focus Areas
Preanalytics for Precision Medicine

Degrees and Training
PhD, Harvard University
MD, Harvard University
BA, Bryn Mawr College

Carolyn Compton, received her MD and PhD from the Harvard Medical School and the Harvard Graduate School of Arts and Sciences, respectively. She is an academic pathologist specializing in gastrointestinal disease. She is a Professor of Life Sciences at Arizona State University, a Professor of Laboratory Medicine and Pathology at the Mayo Clinic School of Medicine, an adjunct Professor of Pathology at the Johns Hopkins Medical Institutions, and the Medical Director of the ASU Biodesign Clinical Testing Laboratory. She is the Chief Medical Officer of the National Biomarker Development Alliance and an Affiliated Scholar in the ASU Center for Healthcare Delivery and Policy. She serves as the Chair of the Precision Medicine Core of the American Joint Committee on Cancer and the Chair of the Preanalytics for Precision Medicine Project Team of the College of American Pathologists. She is the editor-in-chief of the Nature review journal Current Pathobiology Reports. She is a former Professor of Pathology at Harvard Medical School, Chief of Gastrointestinal Pathology at Massachusetts General Hospital, and Pathologist-in-Chief of the Boston Shriners Children’s Hospital. More recently she has served as the CEO and President of the Critical Path Institute (2012), the Director of the Office of Biorepositories and Biospecimen Research and the Director of the Innovative Molecular Analysis Technologies program at the National Cancer Institute (2005-2011), and the Strathcona Professor and Chair of the Department of Pathology at McGill University and Pathologist-in-Chief of the McGill University Health Center (2000-2005).